PeptidePicker
RecoveryResearch

VIP

Also known as: Vasoactive Intestinal Peptide

An endogenous 28-amino-acid neuropeptide that serves as the master regulator of immunity and vascular tone. Definitive intervention for CIRS and mold toxicity.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~2 minutes

Typical Dose

50 mcg (nasal spray)

Administration

Intranasal

Mechanism of Action

Binds VPAC1/VPAC2 receptors to arrest cytokine storms, restore pulmonary function, and modulate innate/adaptive immune balance.

Key Research Areas

immuneCIRSmoldinflammationpulmonary

Frequently Asked Questions

What is VIP?
An endogenous 28-amino-acid neuropeptide that serves as the master regulator of immunity and vascular tone. Definitive intervention for CIRS and mold toxicity.
How does VIP work?
Binds VPAC1/VPAC2 receptors to arrest cytokine storms, restore pulmonary function, and modulate innate/adaptive immune balance.
What is the recommended dosage for VIP?
The typical research dosage is 50 mcg (nasal spray), administered via Intranasal. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of VIP?
The half-life of VIP is approximately ~2 minutes. This affects dosing frequency and timing in research protocols.
Is VIP FDA approved?
VIP is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about VIP is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Recovery